Name: TAK Iclusig Approval
Start: 2025-10-10

TAKEDA PHARMS USA

Approval Confirmed

Iclusig

Resolved

270days ago

Approval decision · Oct 10, 2025

What's at stake A final FDA approval decision on Iclusig for its lead indication is expected Oct 10, 2025.

Primary source · openFDA verified 15h ago

“FDA approved Iclusig (NDA203469) — sponsor TAKEDA PHARMS USA; efficacy supplement (Efficacy); FDA action date 2025-10-10.”

NDA203469 efficacy supplement (Efficacy)

1 source on file.

Link copied ✓